Stem Cell Injections After a Heart Attack Restore the Heart to a Healthy State
August 19, 2012 - (Cleveland.com) - "Early results show these patients end up with hearts that pump at nearly normal rates -- the way they did before the heart attack -- and stay that way for at least a year. Cleveland biotechnology company Athersys Inc., which owns the stem-cell manufacturing process, is playing a significant role in the studies, managing continuing research in heart patients across the country and looking into how stem cells might help treat other conditions." Read Full Article
